CINECA IRIS Institutional Research Information System

PAIAR, FABIOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.528
AS - Asia 5.857
EU - Europa 3.921
SA - Sud America 1.181
AF - Africa 315
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 6
AN - Antartide 1
Totale 22.822
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.291
CN - Cina 2.152
SG - Singapore 1.690
IT - Italia 1.400
HK - Hong Kong 1.054
BR - Brasile 974
SE - Svezia 553
VN - Vietnam 435
DE - Germania 357
BG - Bulgaria 353
GB - Regno Unito 257
AT - Austria 203
FI - Finlandia 187
RU - Federazione Russa 184
CA - Canada 157
FR - Francia 149
CI - Costa d'Avorio 104
IN - India 82
TR - Turchia 81
AR - Argentina 79
NL - Olanda 55
BD - Bangladesh 53
KR - Corea 52
ZA - Sudafrica 50
ID - Indonesia 44
JP - Giappone 44
MX - Messico 43
SN - Senegal 40
PL - Polonia 39
NG - Nigeria 37
EC - Ecuador 33
VE - Venezuela 30
IE - Irlanda 28
MA - Marocco 25
IQ - Iraq 23
CZ - Repubblica Ceca 20
CO - Colombia 19
ES - Italia 19
PK - Pakistan 19
UA - Ucraina 19
KE - Kenya 17
BE - Belgio 15
UZ - Uzbekistan 15
PY - Paraguay 14
CL - Cile 13
EG - Egitto 12
SA - Arabia Saudita 12
IL - Israele 11
RO - Romania 10
CH - Svizzera 9
MY - Malesia 9
AU - Australia 8
DZ - Algeria 8
RS - Serbia 8
TN - Tunisia 8
TW - Taiwan 8
UY - Uruguay 8
AZ - Azerbaigian 7
HU - Ungheria 7
IR - Iran 7
LT - Lituania 7
PE - Perù 7
PH - Filippine 7
PT - Portogallo 7
DO - Repubblica Dominicana 6
HN - Honduras 6
JO - Giordania 6
NO - Norvegia 6
OM - Oman 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
EE - Estonia 5
JM - Giamaica 5
KG - Kirghizistan 5
LK - Sri Lanka 5
BH - Bahrain 4
BO - Bolivia 4
CR - Costa Rica 4
DK - Danimarca 4
EU - Europa 4
GT - Guatemala 4
LV - Lettonia 4
TT - Trinidad e Tobago 4
CY - Cipro 3
GR - Grecia 3
KZ - Kazakistan 3
LB - Libano 3
MG - Madagascar 3
NZ - Nuova Zelanda 3
PA - Panama 3
GA - Gabon 2
LA - Repubblica Popolare Democratica del Laos 2
NP - Nepal 2
PS - Palestinian Territory 2
XK - ???statistics.table.value.countryCode.XK??? 2
AD - Andorra 1
AO - Angola 1
AQ - Antartide 1
BB - Barbados 1
BS - Bahamas 1
Totale 22.796
Salva come PNG Salva come JPEG
Città #
Shanghai 1.210
Woodbridge 1.174
Ashburn 1.137
Fairfield 1.113
Hong Kong 1.047
Singapore 890
Houston 870
Ann Arbor 843
Dallas 814
Santa Clara 677
Chandler 584
Seattle 473
Cambridge 399
Wilmington 388
Sofia 350
Beijing 315
New York 304
Boardman 213
Vienna 190
Los Angeles 188
Princeton 149
Florence 148
Pisa 144
Lawrence 137
Munich 132
London 125
Medford 124
Ho Chi Minh City 122
Serra 113
Abidjan 104
Des Moines 99
Ottawa 96
Frankfurt am Main 80
Rome 80
Redondo Beach 75
São Paulo 74
Milan 73
Buffalo 67
Turku 66
Dearborn 62
Dong Ket 59
Vicopisano 59
Hefei 54
Istanbul 53
Hanoi 49
Nanjing 46
San Diego 45
Lucca 44
Dakar 40
Düsseldorf 40
Lancaster 39
Pietrasanta 39
Seoul 39
Lagos 38
Cascina 33
Fuzhou 31
Tokyo 31
Bremen 30
Warsaw 30
Boulder 28
Rio de Janeiro 26
Toronto 25
Cape Town 23
Helsinki 23
San Francisco 23
Belo Horizonte 22
Ogden 22
Quanzhou 22
Chicago 21
Columbus 20
Denver 20
Phoenix 20
Porto Alegre 20
Amsterdam 19
Bientina 19
Curitiba 19
Montreal 19
Dublin 18
Poplar 18
Redwood City 18
Massa E Cozzile 17
Brasília 16
Brooklyn 16
Guangzhou 16
Shenyang 16
Changsha 15
Nairobi 15
San Jose 15
The Dalles 15
Camaiore 14
Paris 14
Tashkent 14
Tianjin 14
Detroit 13
Guayaquil 13
Hebei 13
Johannesburg 13
Mexico City 13
Nanchang 13
Pontedera 13
Totale 16.781
Salva come PNG Salva come JPEG
Nome #
Stereotactic body radiotherapy with CyberKnife for cardiac malignancies 774
Association of Glutathione S-Transferase P-1 (GSTP-1) rs1695 polymorphism with overall survival in glioblastoma patients treated with combined radio-chemotherapy 254
From a waiting list to a priority list: A computerized model for an easy-to-manage and automatically updated priority list in the booking of patients waiting for radiotherapy 254
Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial 231
Qual è l’effetto della radioterapia sulla funzionalità deglutitoria nei pazienti con tumore del rinofaringe e orofaringe? Risultati a breve termine di uno studio prospettico 221
The effectiveness of bevacizumab in radionecrosis after radiosurgery of a single brain metastasis 220
Association of XRCC3 rs1799794 polymorphism with survival of glioblastoma multiforme patients treated with combined radio-chemotherapy 213
Acute and late vaginal toxicity after adjuvant high-dose-rate vaginal brachytherapy in patients with intermediate risk endometrial cancer: Is local therapy with hyaluronic acid of clinical benefit? 200
Bevacizumab for the Treatment of Radiation-Induced Cerebral Necrosis: A Systematic Review of the Literature 196
Non-melanoma skin cancer treated with high-dose-rate brachytherapy: a review of literature 188
Role of perfusion CT in the evaluation of functional primary tumour response after radiochemotherapy in head and neck cancer: Preliminary findings 187
Salvage Hypofractionated Radiotherapy in Combination with Bevacizumab in Patients with Recurrent High Grade Glioma: A Mono-institutional Experience 184
Melanocortin Receptor-4 Gene Polymorphisms in Glioblastoma Patients Treated with Concomitant Radio-Chemotherapy 182
Application of helical tomotherapy for the treatment of a right atrium angiosarcoma: A case report 181
Accelerated intensity-modulated external radiotherapy as a new technical approach to treat the index quadrant after conserving surgery in early breast cancer: a preliminary study 180
Prognostic role of internal jugular vein preservation in neck dissection for head and neck cancer 173
Contouring of the pharyngeal superior constrictor muscle (PSCM): a cooperative study of the Italian Association of Radiation Oncology (AIRO) Head and Neck Group 172
Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial 169
Adjuvant hypofractionated radiation therapy for breast cancer after conserving surgery 165
Hypofractionation in prostate cancer: Radiobiological basis and clinical appliance 165
Subtotal supracricoid laryngectomy: Changing in indications, surgical techniques and use of new surgical devices 162
Survival outcomes following repeat surgery for recurrent glioblastoma: a single-center retrospective analysis 161
Clinical Outcomes of Stereotactic Body Radiotherapy in Oligometastatic Gynecological Cancer 160
Tubular carcinoma of the breast: Outcome and loco-regional recurrence in 307 patients 160
[18F]Fluorocholine PET/CT-guided stereotactic body radiotherapy in patients with recurrent oligometastatic prostate cancer 156
Benefit of Radiation Boost After Whole-Breast Radiotherapy 155
IDH1 mutation is detectable in plasma cell-free DNA and is associated with survival outcome in glioma patients 154
Non-melanoma skin cancer treated with high-dose-rate brachytherapy: A review of literature 153
Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. II. The case of T2N0 disease 152
Adjuvant chemoradiotherapy (gemcitabine-based) in pancreatic adenocarcinoma: The Pisa University experience 152
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study 152
Four-dimensional computed tomography in accelerated partial breast irradiation planning: single series from a phase III trial 152
EP-1568 Long-term results of [18F] Fluorocholine PET/CT guided SBRT in patients with prostate cancer 152
Surface imaging, portal imaging, and skin marker set-up vs. CBCT for radiotherapy of the thorax and pelvis 151
Breast cancer in the elderly: Treatment of 1500 patients 150
Treatment of epithelioid sarcoma at the Royal Marsden Hospital 149
Alternating intravenous and oral vinorelbine plus epirubicin with pegfilgrastim as neoadjuvant treatment of locally advanced breast cancer 149
Adjuvant trastuzumab in breast cancer: Experience from the University of Florence 149
Loco-regional recurrence in 2064 patients with breast cancer treated with mastectomy without adjuvant radiotherapy 148
Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer 148
Non-melanoma skin cancer treated with high-doserate brachytherapy and Valencia applicator in elderly patients: a retrospective case series 147
Low prevalence of K-RAS, EGF-R and BRAF mutations in sinonasal adenocarcinomas. Implications for anti-EGFR treatments 147
The role of clinicopathologic and molecular prognostic factors in the post-mastectomy radiotherapy (PMRT): a retrospective analysis of 912 patients 146
Accelerated Partial Breast Irradiation With IMRT: New Technical Approach and Interim Analysis of Acute Toxicity in a Phase III Randomized Clinical Trial 145
Role of perfusion CT in the evaluation of metastatic nodal tumor response after radiochemotherapy in head and neck cancer: preliminary findings 145
null 145
Radiation-induced nausea and vomiting in head and neck cancer: Is it something worth considering in the intensity modulated radiotherapy era? "A narrative review" 144
Incorporating dose–volume histogram parameters of swallowing organs at risk in a videofluoroscopy-based predictive model of radiation-induced dysphagia after head and neck cancer intensity-modulated radiation therapy 143
Treatment of uterine sarcoma at the Royal Marsden Hospital from 1974 to 1998 142
Salvage stereotactic re-irradiation with CyberKnife for locally recurrent head and neck cancer: A single center experience 142
Treatment of uterine sarcoma at the University of Florence from 1980-2001 141
Uterine sarcoma: twenty-seven years of experience 140
Single-fraction flattening filter–free volumetric modulated arc therapy for lung cancer: Dosimetric results and comparison with flattened beams technique 139
Different timing to use bevacizumab in patients with recurrent glioblastoma: Early versus delayed administration 139
Survival and breast relapse in 3834 patients with T1-T2 breast cancer after conserving surgery and adjuvant treatment 138
Prognostic factors and clinical features in patients with leptominengeal metastases from breast cancer: A single center experience 138
Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. I. The case of T1N0 disease 137
Surgical options in radiotherapy-failed early glottic cancer 137
High-dose-rate brachytherapy for non-melanoma skin cancer using tailored custom moulds – a single-centre experience 137
Cancer Stem Cells and Glioblastoma: Time for Innovative Biomarkers of Radio-Resistance? 136
IOERT in Breast Cancer: Results of Ten-Year Follow-Up in an Italian Experience Confirm High Local Recurrence Rate 136
Circulating tumour cells in locally advanced head and neck cancer: Preliminary report about their possible role in predicting response to non-surgical treatment and survival 136
Set-up errors in head and neck cancer treated with IMRT technique assessed by cone-beam computed tomography: a feasible protocol 136
Image-guided Stereotactic Body Radiotherapy in Metastatic Prostate Cancer 135
Regional Oncotherapies 134
Quality of life after radical treatment of prostate cancer: Validation of the Italian version of the University of California-Los Angeles Prostate Cancer Index 134
Definitive Radiotherapy for Primary Squamous Cell Carcinoma of the Vagina: Are High-Dose External Beam Radiotherapy and High-Dose-Rate Brachytherapy Boost the Best Treatment? Experience of Two Italian Institutes 134
Adjuvant Radiotherapy in High-Risk Squamous Cell Carcinoma of the Vulva: A Two-Institutional Italian Experience 134
Impact of recurrence pattern in patients undergoing a second surgery for recurrent glioblastoma 134
Outcome After Conservative Surgery and Breast Irradiation in 5,717 Patients With Breast Cancer: Implications for Supraclavicular Nodal Irradiation 133
Dabrafenib treatment in a patient with BRAF V600E ganglioglioma: circulating exosome-derived cancer RNA supports treatment choice and clinical monitoring 133
NAVIGATOR: A regional multimodal imaging biobank initiative powered by AI tools for precision medicine in oncology 132
Reirradiation in head and neck recurrent or second primary tumor: efficacy, safety, and prognostic factors 132
Head and neck radiotherapy amid the COVID‑19 pandemic: practice recommendations of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 132
Bipolar disorder treatments and ovarian cancer: A systematic review 132
Stage I seminoma of the testis: a bi-institutional retrospective analysis of patients treated with radiation therapy only 131
Concomitant external-beam irradiation and chemotherapy followed by high-dose rate brachytherapy boost in the treatment of squamous cell carcinoma of the vagina: A single-center retrospective study 131
Loco regional failure pattern after lumpectomy and breast irradiation in 4185 patients with T1 and T2 breast cancer. Implications for nodal irradiation 131
Radiomics and liquid biopsy in oncology: the holons of systems medicine 131
Radiation-Related Dysphagia: From Pathophysiology to Clinical Aspects 131
How does radiotherapy impact swallowing function in nasopharynx and oropharynx cancer? Short-term results of a prospective study Qual è l’effetto della radioterapia sulla funzionalità deglutitoria nei pazienti con tumore del rinofaringe e orofaringe? Risultati a breve termine di uno studio prospettico 130
A multicenter real-world study of bevacizumab in heavily pretreated malignant gliomas: Clinical benefit is a plausible end point? 129
Single-agent Bevacizumab in Recurrent Glioblastoma After Second-line Chemotherapy With Fotemustine: The Experience of the Italian Association of Neuro-Oncology 127
Squamous cell carcinoma (SCC) of the Pyriform sinus with multiple metachronous brain metastases, a case report 127
Old and New Systemic Immune-Inflammation Indexes Are Associated with Overall Survival of Glioblastoma Patients Treated with Radio-Chemotherapy 126
Stereotactic Body Radiotherapy in Patients with Lung Oligometastases from Colorectal Cancer 126
Doxorubicin and cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil as adjuvant chemotherapy in breast cancer 126
Simultaneous integrated boost-intensity-modulated radiotherapy in head and neck cancer 125
In phantom assessment of superficial doses under TomoTherapy irradiation 125
Localized prostate cancer treated with intensity-modulated radiotherapy 125
Methods and advanced equipment for simulation and treatment in radiation oncology. Programa MAESTRO 124
Late treatment-related complications in 214 patients with extremity soft-tissue sarcoma treated by surgery and postoperative radiation therapy 123
Clinical outcome of stereotactic body radiotherapy for abdominal lymph node metastases 123
Radiotherapy Timing in 4,820 Patients With Breast Cancer: University of Florence Experience 121
Patterns of Failures and Clinical Outcome of Patients with Early-Stage, High-Risk, Node-Negative Endometrial Cancer Treated with Surgery Followed by Adjuvant Platinum-Based Chemotherapy and Vaginal Brachytherapy 121
Radiotherapy in the COVID-19 Pandemic Era 121
Adjuvant radiotherapy in patients with pancreatic adenocarcinoma. Is it still appealing in clinical trials? A meta-analysis and review of the literature 121
Impact of recurrence pattern in patients undergoing a second surgery for recurrent glioblastoma 121
Photon-based High-dose Single-fraction Radiosurgery, an Effective Treatment Modality for Large and Posterior Uveal Melanoma 121
A new calculation method for the free electron fraction of an ionization chamber in the ultra-high-dose-per-pulse regimen 121
Totale 15.547
Salva come PNG Salva come JPEG
Categoria #
all - tutte 66.721
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.721
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021816 0 0 0 0 0 76 151 64 201 78 71 175
2021/20221.518 36 60 25 69 277 231 56 83 78 50 122 431
2022/20232.166 246 287 169 147 247 285 26 153 399 9 164 34
2023/20241.458 82 114 149 226 150 273 66 50 44 52 75 177
2024/20256.323 95 204 60 331 447 589 1.310 264 608 702 643 1.070
2025/20264.640 438 1.049 943 941 746 523 0 0 0 0 0 0
Totale 23.231